Register entry

Kedrion Biopharma Inc.

Data as of · How to read this entry

Registered sites
3
Active NDC listings
28
Labeller names
6
Live patents
0
Countries
2
Base
Italy
Authorisation

Registered operations

Active ingredient (API) manufacture1Labelling1Finished drug manufacture2Packaging1
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Kedrion S.p.A.Via Giovanni Pascoli, Barga, Lucca 55051, Italy (ITA)Active ingredient (API) manufacture3009166014434338887
Kedrion S.p.A.Via Di Fondovalle, Bolognana, Lucca 55027, Italy (ITA)Labelling, Finished drug manufacture, Packaging3008919567339096023
Kedrion Biopharma Inc.155 Duryea Road, Melville, New York (NY) 11747, United States (USA)Finished drug manufacture3003683714080452111
Catalogue

Drug listings by form and route

28

28 active NDC listings: 27 plasma derivative, 1 human prescription drug. By marketing category: BLA 28.

Dosage formNDCs
kit18
injection, solution4
solution4
injection1
injection, powder, lyophilized, for solution1
RouteNDCs
intravenous23
intramuscular2
subcutaneous1
Labeller name on the listingNDCs
kedrion biopharma, inc.22
kedrion biopharma inc2
kedrion biopharma inc.1
kedrion biopharma, inc.1
kedrion s.p.a1
kedrion s.p.a.1
Catalogue

Marketed products

28
BrandGeneric nameForm / routeNDC
AlbukedAlbumin (Human)solution, intravenous76125-790BLA
AlbukedAlbumin (Human)solution, intravenous76125-791BLA
AlbukedAlbumin (Human)solution, intravenous76125-792BLA
GAMMAKEDImmune Globulin (Human)injection, intravenous, subcutaneous76125-900BLA
KEDBUMINAlbumin (Human)injection, solution, intravenous76179-025BLA
KEDRABHUMAN RABIES VIRUS IMMUNE GLOBULINinjection, solution, intramuscular76125-150BLA
KoateAntihemophilic Factor (Human)kit76125-250BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-253BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-256BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-257BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-258BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-259BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-661BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-662BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-663BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-665BLA
KoateAntihemophilic Factor (Human)kit76125-667BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-668BLA
KoateAntihemophilic Factor (Human)kit76125-672BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-674BLA
KoateAntihemophilic Factor (Human)kit, intravenous76125-675BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-676BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-678BLA
KoateANTIHEMOPHILIC FACTOR (HUMAN)kit, intravenous76125-679BLA
QIVIGY kthmhuman immunoglobulin ginjection, solution, intravenous76179-010BLA
RhoGAM Ultra-Filtered PLUSHUMAN RHO(D) IMMUNE GLOBULINinjection, solution, intramuscular0562-7805BLA
Ryplazimplasminogeninjection, powder, lyophilized, for solution, intravenous70573-099BLA
YIMMUGOimmune globulin intravenous, human - dirasolution, intravenous70573-605BLA
Neighbours

Registered in the same town

2
Compare

Comparable companies in Italy

Enquiry

Common questions

Is Kedrion Biopharma Inc. FDA approved?
Kedrion Biopharma Inc. holds 3 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Kedrion Biopharma Inc.'s drugs manufactured?
At registered sites in Italy, the United States. The FDA register lists Barga; Bolognana; Melville, NY. Registered operations: active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Kedrion Biopharma Inc. make?
28 products are listed under Kedrion Biopharma Inc. in the openFDA NDC Directory, most often as kit; injection, solution; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.